Last 48 quarters of trend data · Consumer Defensive · Beauty & Personal Care
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.85 | — | — | 48.92 | 8.29 | 8.96 | 4.65 | 0.85 | — | 10.84 | — | — | 32.37 | — | 15.37 | 42.73 | 9.17 | — | 16.16 | 15.75 | — |
| — | — | — | +5668.5% | — | -17.3% | — | — | — | — | — | — | +253.1% | — | -4.9% | +171.3% | — | — | +31.2% | +8.4% | — | |
| P/S Ratio | 0.15 | 0.18 | 0.20 | 0.28 | 0.32 | 0.42 | 0.26 | 0.25 | 0.19 | 0.21 | 0.30 | 0.41 | 0.49 | 0.53 | 0.83 | 1.02 | 1.00 | 0.78 | 0.98 | 1.01 | 0.96 |
| — | -57.9% | -21.7% | +11.9% | +68.7% | +97.6% | -14.1% | -38.9% | -60.9% | -59.8% | -64.2% | -59.8% | -51.1% | -31.9% | -15.4% | +1.1% | +5.0% | -3.7% | -5.1% | -0.8% | +2.2% | |
| P/B Ratio | 0.26 | 0.40 | 0.47 | 0.45 | 0.60 | 0.77 | 0.50 | 0.48 | 0.53 | 0.52 | 0.76 | 0.85 | 1.17 | 1.29 | 1.86 | 2.20 | 2.34 | 1.99 | 2.34 | 2.62 | 2.82 |
| — | -47.5% | -5.8% | -6.5% | +13.4% | +47.9% | -34.2% | -42.7% | -55.0% | -59.7% | -59.0% | -61.6% | -50.0% | -35.4% | -20.7% | -15.8% | -17.2% | -10.2% | -26.3% | -17.3% | -9.9% | |
| P/FCF | — | — | 12.86 | — | 20.48 | 8.73 | 2.76 | — | 6.49 | 4.01 | 3.04 | — | 7.11 | 6.76 | 20.01 | — | 44.68 | 140.30 | 14.90 | — | 7.06 |
| — | — | +365.4% | — | +215.8% | +117.5% | -9.1% | — | -8.8% | -40.6% | -84.8% | — | -84.1% | -95.2% | +34.2% | — | +532.8% | +351.2% | -93.4% | — | -19.7% | |
| EV / EBITDA | 25.39 | 15.14 | — | 6.02 | 4.19 | 4.84 | 2.52 | 26.86 | — | 4.50 | — | 9.45 | 9.84 | — | 8.43 | 16.92 | 12.79 | — | 8.41 | 9.43 | 17.68 |
| — | +212.8% | — | -77.6% | — | +7.4% | — | +184.4% | — | — | — | -44.2% | -23.0% | — | +0.2% | +79.5% | -27.7% | — | +13.6% | +5.1% | +161.8% | |
| EV / EBIT | 3.57 | — | — | 16.02 | 6.83 | 8.11 | 3.69 | 0.84 | — | 8.09 | — | 30.56 | 35.17 | — | 11.73 | 28.71 | 12.84 | 47.86 | 11.45 | 12.53 | 9.50 |
| — | — | — | +1810.6% | — | +0.2% | — | -97.3% | — | — | — | +6.4% | +173.8% | — | +2.4% | +129.2% | +35.2% | +449.9% | +25.8% | +8.1% | +16.2% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.4% | 65.0% | 68.2% | 66.9% | 70.7% | 70.5% | 68.8% | 67.8% | 62.7% | 70.1% | 70.0% | 70.5% | 72.1% | 58.6% | 72.9% | 72.3% | 71.7% | 67.7% | 73.6% | 73.3% | 74.2% |
| — | -7.8% | -0.9% | -1.3% | +12.9% | +0.6% | -1.6% | -3.8% | -13.1% | +19.6% | -4.0% | -2.5% | +0.6% | -13.5% | -0.9% | -1.4% | -3.4% | -9.9% | -2.6% | -2.0% | +0.3% | |
| Operating Margin | 6.1% | 1.6% | -18.5% | 1.8% | 6.3% | 5.9% | 8.0% | -2.7% | -11.9% | 4.2% | -28.6% | 2.1% | 3.3% | -5.3% | 8.5% | 3.3% | 5.3% | -3.8% | 9.2% | 8.6% | 3.0% |
| — | -72.5% | -332.5% | +167.3% | +152.7% | +40.2% | +127.9% | -228.5% | -462.4% | +180.2% | -436.5% | -36.6% | -37.5% | -40.2% | -7.6% | -61.3% | +74.2% | -137.0% | -24.2% | -7.2% | -74.5% | |
| Net Margin | 10.8% | -0.2% | -78.0% | 0.6% | 3.9% | 4.7% | 5.5% | 29.5% | -8.1% | 1.9% | -26.9% | -0.1% | 1.5% | -7.4% | 5.4% | 2.4% | 11.0% | -4.7% | 6.1% | 6.4% | -1.4% |
| — | -105.1% | -1526.8% | -98.1% | +148.3% | +143.0% | +120.3% | +23199.0% | -643.7% | +126.0% | -601.0% | -105.4% | -86.4% | -56.9% | -12.0% | -63.1% | +899.1% | -160.9% | -27.5% | -8.6% | -114.0% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 22.0% | -0.1% | -37.4% | 0.2% | 1.8% | 2.2% | 2.7% | 15.3% | -5.3% | 1.2% | -15.8% | -0.1% | 0.9% | -4.3% | 3.0% | 1.3% | 6.6% | -2.8% | 3.7% | 4.2% | -1.0% |
| — | -106.3% | -1464.1% | -98.5% | +134.0% | +80.5% | +117.3% | +23530.3% | -700.1% | +127.7% | -625.6% | -105.1% | -86.5% | -51.1% | -17.6% | -69.7% | +759.0% | -153.1% | -44.9% | -22.0% | -111.7% | |
| ROA | 11.1% | -0.1% | -20.0% | 0.1% | 1.0% | 1.2% | 1.5% | 7.5% | -2.4% | 0.5% | -7.1% | -0.0% | 0.4% | -2.0% | 1.4% | 0.6% | 3.2% | -1.4% | 1.8% | 2.0% | -0.5% |
| — | -105.6% | -1442.3% | -98.2% | +143.3% | +127.3% | +121.0% | +25159.0% | -685.1% | +126.1% | -591.4% | -104.8% | -87.3% | -44.6% | -19.9% | -69.4% | +771.2% | -156.1% | -39.2% | -16.0% | -112.2% | |
| ROIC | 7.3% | 0.6% | -6.0% | 0.5% | 2.0% | 1.9% | 2.7% | -0.8% | -4.1% | 1.4% | -8.8% | 0.6% | 1.0% | -1.6% | 2.7% | 1.0% | 1.9% | -1.4% | 3.5% | 3.6% | 1.4% |
| — | -68.6% | -318.0% | +158.9% | +147.6% | +39.8% | +131.2% | -245.7% | -500.8% | +184.3% | -430.9% | -45.4% | -44.7% | -16.1% | -24.6% | -71.0% | +35.8% | -132.4% | -41.4% | -23.1% | -80.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.45 | 0.46 | 0.49 | 0.35 | 0.45 | 0.36 | 0.39 | 0.40 | 0.73 | 0.71 | 0.77 | 0.69 | 0.74 | 0.69 | 0.65 | 0.56 | 0.58 | 0.60 | 0.55 | 0.50 | 0.55 |
| — | +26.5% | +23.2% | -12.3% | -38.4% | -48.7% | -48.8% | -42.0% | -0.6% | +2.2% | +18.5% | +23.1% | +27.4% | +16.3% | +18.3% | +11.1% | +5.1% | +15.5% | -6.8% | -11.7% | -1.4% | |
| Debt / EBITDA | 2.54 | 49.62 | — | 15.25 | 10.07 | 8.64 | 7.09 | 69.88 | — | 14.12 | — | 20.45 | 18.23 | — | 9.76 | 15.10 | 11.31 | — | 7.37 | 6.78 | 12.99 |
| — | +474.4% | — | -78.2% | — | -38.8% | — | +241.8% | — | — | — | +35.4% | +61.2% | — | +32.3% | +122.6% | -12.9% | — | +42.9% | +11.0% | +178.8% | |
| Current Ratio | 2.08 | 2.04 | 1.98 | 2.03 | 2.08 | 2.15 | 2.01 | 2.02 | 1.82 | 1.93 | 2.12 | 2.09 | 2.13 | 1.62 | 1.78 | 2.08 | 2.12 | 2.13 | 2.30 | 1.72 | 1.65 |
| — | -5.4% | -1.5% | +0.9% | +14.4% | +11.9% | -5.1% | -3.6% | -14.9% | +19.2% | +19.1% | +0.8% | +0.9% | -24.1% | -22.5% | +20.8% | +28.3% | +29.1% | +47.3% | +7.1% | -0.9% | |
| Quick Ratio | 1.40 | 1.22 | 1.24 | 1.34 | 1.38 | 1.45 | 1.38 | 1.29 | 1.17 | 1.20 | 1.33 | 1.24 | 1.28 | 0.94 | 0.94 | 1.09 | 1.15 | 1.23 | 1.38 | 0.95 | 0.89 |
| — | -15.8% | -10.3% | +3.8% | +17.5% | +21.5% | +3.6% | +4.5% | -8.4% | +26.5% | +40.8% | +13.2% | +11.4% | -23.3% | -31.4% | +15.5% | +29.0% | +40.0% | +48.7% | -1.2% | -17.7% | |
| Interest Coverage | 15.07 | 1.45 | -18.02 | 1.61 | 5.55 | 4.86 | 11.85 | 42.00 | -8.86 | 3.05 | -18.59 | 1.15 | — | -4.57 | 7.43 | 3.98 | 14.76 | 0.25 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NUS stock.
Nu Skin Enterprises, Inc.'s current P/E is -0.9x. The average P/E over the last 2 quarters is 28.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Nu Skin Enterprises, Inc.'s current operating margin is 6.1%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Nu Skin Enterprises, Inc.'s business trajectory between earnings reports.